Access

Letters to Nature

Nature 401, 493-497 (30 September 1999) | doi:10.1038/46816; Received 22 April 1999; Accepted 28 July 1999

Open Innovation Challenges

Cytochrome P450 2C is an EDHF synthase in coronary arteries

Beate Fisslthaler1, Rüdiger Popp1, Ladislau Kiss2, Michael Potente1, David R. Harder3, Ingrid Fleming1 & Rudi Busse1

  1. Institut für Kardiovaskuläre Physiologie, Klinikum der J. W. Goethe-Universität, Theodor-Stern-Kai 7, D-60590 Frankfurt am Main, Germany
  2. Zentrum der Inneren Medizin, Justus Liebig Universität Gies zligen, Klinikstrasse 36, D-35392 Gies zligen, Germany
  3. Cardiovascular Research Center, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, USA

Correspondence to: Ingrid Fleming1 Correspondence and requests for material should be addressed to I.F. (e-mail: Email: fleming@em.uni-frankfurt.de).

Top

In most arterial beds a significant endothelium-dependent dilation to various stimuli persists even after inhibition of nitric oxide synthase and cyclo-oxygenase. This dilator response is preceded by an endothelium-dependent hyperpolarization of vascular smooth muscle cells, which is sensitive to a combination of the calcium-dependent potassium-channel inhibitors charybdotoxin and apamin, and is assumed to be mediated by an unidentified endothelium-derived hyperpolarizing factor (EDHF)1, 2. Here we show that the induction of cytochrome P450 (CYP) 2C8/34 in native porcine coronary artery endothelial cells by beta-naphthoflavone enhances the formation of 11,12-epoxyeicosatrienoic acid, as well as EDHF-mediated hyperpolarization and relaxation. Transfection of coronary arteries with CYP 2C8/34 antisense oligonucleotides results in decreased levels of CYP 2C and attenuates EDHF-mediated vascular responses. Thus, a CYP-epoxygenase product is an essential component of EDHF-mediated relaxation in the porcine coronary artery, and CYP 2C8/34 fulfils the criteria for the coronary EDHF synthase.